148 related articles for article (PubMed ID: 21340193)
61. Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis.
McKee RF; Krukowski ZH; Matheson NA
Br J Surg; 1993 Oct; 80(10):1303-4. PubMed ID: 8242306
[TBL] [Abstract][Full Text] [Related]
62. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients.
Ma B; Chen X; Zhao Z; Yin X; Ji Q; Zhou Y; Ma C; Wang J
BMC Endocr Disord; 2022 Mar; 22(1):55. PubMed ID: 35255870
[TBL] [Abstract][Full Text] [Related]
63. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
[TBL] [Abstract][Full Text] [Related]
64. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology.
Farahati J; Bucsky P; Parlowsky T; Mäder U; Reiners C
Cancer; 1997 Dec; 80(11):2156-62. PubMed ID: 9392339
[TBL] [Abstract][Full Text] [Related]
65. Chronic Lymphocytic Thyroiditis and Aggressiveness of Pediatric Differentiated Thyroid Cancer.
Yeker RM; Shaffer AD; Viswanathan P; Witchel SF; Mollen K; Yip L; Monaco SE; Duvvuri U; Simons JP
Laryngoscope; 2022 Aug; 132(8):1668-1674. PubMed ID: 34687456
[TBL] [Abstract][Full Text] [Related]
66. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
68. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
69. LYMPHOCYTIC THYROIDITIS IS ASSOCIATED WITH INCREASED NUMBER OF BENIGN CERVICAL NODES AND FEWER CENTRAL NECK COMPARTMENT METASTATIC LYMPH NODES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
Donangelo I; Walts AE; Bresee C; Braunstein GD
Endocr Pract; 2016 Oct; 22(10):1192-1198. PubMed ID: 27732096
[TBL] [Abstract][Full Text] [Related]
70. [Analysis of variation trends of thyroid cancer treated in Tianjin Cancer Hospital form 1954 to 2009].
Wei SF; Gao M; Qian BY; Li YG; Zhang Y; Chen WY; Zheng XQ; Li XL; Yu Y; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):613-5. PubMed ID: 22325223
[TBL] [Abstract][Full Text] [Related]
71. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study.
Mazokopakis EE; Tzortzinis AA; Dalieraki-Ott EI; Tsartsalis AN; Syros PK; Karefilakis CM; Papadomanolaki MG; Starakis IK
Hormones (Athens); 2010; 9(4):312-7. PubMed ID: 21112862
[TBL] [Abstract][Full Text] [Related]
72. Differentiated thyroid cancer in children and adolescents.
Farahati J; Parlowsky T; Mäder U; Reiners C; Bucsky P
Langenbecks Arch Surg; 1998 Aug; 383(3-4):235-9. PubMed ID: 9776448
[TBL] [Abstract][Full Text] [Related]
73. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
74. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
[No Abstract] [Full Text] [Related]
75. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
Lee J; Hasteh F
Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
[TBL] [Abstract][Full Text] [Related]
76. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
77. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy.
Côrtes MCS; Rosario PW; Mourão GF; Calsolari MR
Braz J Otorhinolaryngol; 2018; 84(4):448-452. PubMed ID: 28625809
[TBL] [Abstract][Full Text] [Related]
78. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
80. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
